Cancer spreads fast and hits hard, especially when it reaches other organs. Once that happens, treatments become less ...

Cancers in Other Organs Expected to be Next Targets for Non-Surgical Approach The latest advancement in the treatment of ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant ...

How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...

The clinical trial will include nearly 150 patients with advanced hepatocellular carcinoma that expresses glypican-3.

Hepatocellular carcinoma (HCC) is a common malignant tumor and the third leading cause of cancer-related mortality. The lack ...

LIVER CANCER, the third leading cause of cancer-related deaths globally, is primarily attributed to hepatocellular carcinoma ...

SIRT with 90Y resin microspheres led to durable disease control in patients with gastrointestinal stromal tumor liver ...

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.